Dyne Therapeutics (DYN) Stock
Dyne Therapeutics (DYN) closed at $16.02 on Nov 17, 2026; its Tenet Score is 52 of 100 against 340 Healthcare peers.
34 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $16.02
- Nov 17, 2026
- Market cap
- $3.1B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 14.00 – 27.30
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 52/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Dyne Therapeutics Inc scores 52/100. Mixed. Strongest on financial health, quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 52 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
13F flows & insider trades land here.
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne m…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Arcutis Biotherapeutics IncARQT | 43 | $3.4B |
| Viking Therapeutics IncVKTX | 36 | $3.4B |
| Supernus Inc.SUPN | 53 | $3.4B |
| Acadia Pharmaceuticals IncACAD | 65 | $3.2B |
| Bausch Health Companies IncBHC | 51 | $3.2B |
| Xeris Biopharma Holdings IncXERS | 48 | $3.1B |
| Adma Biologics IncADMA | 72 | $3.0B |
| Ideaya Biosciences IncIDYA | 57 | $2.9B |
| Vericel CorpVCEL | 61 | $2.9B |
| Denali Therapeutics IncDNLI | 54 | $2.9B |
Common questions
What sector and industry is Dyne Therapeutics in?
Dyne Therapeutics is in the Healthcare sector and the Drugs industry.
What is Dyne Therapeutics' Tenet Score?
Dyne Therapeutics' Tenet Score is 52 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




